Salesforce has rolled out new features to target specific segments of the life sciences sector – the medical device companies and the pharmaceutical industry with the Salesforce Health Cloud. The buildup of the Health Cloud is a part of the world’s number 1 customer relationship management (CRM) company to come strongly over peers like Oracle and SAP with industry-specific software.
The Salesforce Health Cloud now provides out-of-the-box tools for the pharmaceutical industry that would help companies engage directly with patients. The list includes the new Guided Program Enrollment feature that lets a life sciences company work in synchronization with health care providers for easily creating therapeutic support programs.
Using Guided Program Enrollment, pharmaceutical companies can set up a drug treatment program for patients by easily arranging insurance verification, patient onboarding, co-pay programs, and other elements. This will ensure that all critical elements are easily set up for the treatment program and ensure that the program is being adhered to by patients.
Dr. Ashwini Zenooz, Salesforce’s SVP and GM for Healthcare and Life Sciences, said Salesforce has been hearing a lot from its life sciences customers and they want to engage better with patients. Zenooz added the patients want to be more engaged with life science companies.
New survey data was published by Salesforce that lined up with this notion. This report suggested that 62 percent of healthcare consumers are of the view that it is very important for pharmaceutical companies to help them make smarter and informed decisions by educating them on how to get the best value from their medication. The survey, which surveyed approximately 6,000 global healthcare consumers about their experiences and expectations, also revealed that only 40 percent of consumers believe the communications they receive from the life sciences and healthcare industries are of relevance to them.
The Guided Program Enrollment feature of the Salesforce Health Cloud aims to facilitate the more personal, data-driven conversations that patients are expecting from pharmaceutical companies. The CRM giant – Salesforce – is also introducing a Patient Services Consent Management feature to enable medical device and pharmaceutical companies to easily and quickly view consent forms and capture the consent of patients with an eSignature.
Salesforce is also bringing new sales agreement capabilities to the Health Cloud along with account-based forecasting. The Sales Agreement capabilities would assist medical device companies to manage volume, price, sales, and revenue commitments, allowing their sales and operations teams to jointly track whether customers are satisfying their commitments.